Competing actions of type 1 angiotensin II receptors expressed on t lymphocytes and kidney epithelium during cisplatin-induced aki

Journal of the American Society of Nephrology

Volumn 27, Issue 8, 2016, Pages 2257-2264

  Zhang, Jiandong ^a   Rudemiller, Nathan P ^a   Patel, Mehul B ^a   Wei, Qingqing ^b   Karlovich, Norah S ^a   Jeffs, Alexander D ^a   Wu, Min ^a   Sparks, Matthew A ^a   Privratsky, Jamie R ^c   Herrera, Marcela ^a   Gurley, Susan B ^a   Nedospasov, Sergei A ^d   Crowley, Steven D ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

^d ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; CISPLATIN; CREATININE; NITROGEN; TUMOR NECROSIS FACTOR;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL TRACKING; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOKINE PRODUCTION; DISEASE EXACERBATION; DISEASE SEVERITY; EPITHELIUM CELL; KIDNEY EPITHELIUM; KIDNEY TUBULE EPITHELIUM; LYMPHOCYTIC INFILTRATION; MOUSE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; UREA NITROGEN BLOOD LEVEL; ANIMAL; BIOSYNTHESIS; CHEMICALLY INDUCED; EPITHELIUM; FEMALE; KIDNEY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ACUTE KIDNEY INJURY; ANIMALS; CISPLATIN; EPITHELIUM; FEMALE; KIDNEY; MICE; RECEPTOR, ANGIOTENSIN, TYPE 1; T-LYMPHOCYTES;

EID: 85015765031     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2015060683     Document Type: Article

References (31)

1. Kelland L: The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer 7: 573-584, 2007
2. Dasari S, Tchounwou PB: Cisplatin in cancer therapy: Molecular mechanisms of action. Eur J Pharmacol 740: 364-378, 2014
3. Pabla N, Dong Z: Curtailing side effects in chemotherapy: A tale of PKCd in cisplatin treatment. Oncotarget 3: 107-111, 2012
4. Bao H, Ge Y, Wang Z, Zhuang S, Dworkin L, Peng A, Gong R: Delayed administration of a single dose of lithium promotes recovery from AKI. J Am Soc Nephrol 25: 488-500, 2014
5. Ramesh G, Reeves WB: TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest 110: 835-842, 2002
6. Zhang B, Ramesh G, Norbury CC, Reeves WB: Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-alpha produced by renal parenchymal cells. Kidney Int 72: 37-44, 2007
7. Crowley SD,GurleySB,OliverioMI,PazminoAK, Griffiths R, Flannery PJ, Spurney RF, Kim HS, Smithies O, Le TH, Coffman TM: Distinct roles for the kidney and systemic tissues in blood pressure regulation by the reninangiotensin system. J Clin Invest 115: 1092-1099, 2005
8. Zhang JD, Patel MB, Song YS, Griffiths R, Burchette J, Ruiz P, Sparks MA, Yan M, HowellDN,Gomez JA,SpurneyRF,CoffmanTM, Crowley SD: A novel role for type 1 angiotensin receptors on T lymphocytes to limit target organ damage in hypertension. Circ Res 110: 1604-1617, 2012
9. Zhang JD, Patel MB, Griffiths R, Dolber PC, Ruiz P, Sparks MA, Stegbauer J, Jin H, Gomez JA, Buckley AF, Lefler WS, Chen D, Crowley SD: Type 1 angiotensin receptors on macrophages ameliorate IL-1 receptormediated kidney fibrosis. J Clin Invest 124: 2198-2203, 2014
10. Ferreri NR, Escalante BA, Zhao Y, An SJ, McGiff JC: Angiotensin II induces TNF production by the thick ascending limb: Functional implications. Am J Physiol 274: F148-F155, 1998
11. Liu M, Chien CC, Burne-Taney M, Molls RR, Racusen LC, Colvin RB, Rabb H: A pathophysiologic role for T lymphocytes in murine acute cisplatin nephrotoxicity. J Am Soc Nephrol 17: 765-774, 2006
12. Zhang D, Liu Y, Wei Q, Huo Y, Liu K, Liu F, Dong Z: Tubular p53 regulates multiple genes tomediate AKI. J AmSoc Nephrol 25: 2278-2289, 2014
13. Xu Y, Ma H, Shao J,Wu J, Zhou L, Zhang Z, Wang Y, Huang Z, Ren J, Liu S,Chen X,Han J: A role for tubular necroptosis in cisplatininduced AKI. J Am Soc Nephrol 26: 2647-2658, 2015
14. MullerDN, Shagdarsuren E, Park JK,Dechend R, Mervaala E, Hampich F, Fiebeler A, Ju X, Finckenberg P, Theuer J, Viedt C, Kreuzer J, Heidecke H, Haller H, Zenke M, Luft FC: Immunosuppressive treatment protects against angiotensin II-induced renal damage. Am J Pathol 161: 1679-1693, 2002
15. Muller DN, Dechend R, Mervaala EMA, Park J-K, Schmidt F, Fiebeler A, Theuer J, Breu V, Ganten D, Haller H, Luft FC: NFkappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats. Hypertension 35: 193-201, 2000
16. Crowley SD, Song YS, Sprung G, Griffiths R, Sparks M, Yan M, Burchette JL, Howell DN, Lin EE, Okeiyi B, Stegbauer J, Yang Y, Tharaux PL, Ruiz P: A role for angiotensin II type 1 receptors on bone marrow-derived cells in the pathogenesis of angiotensin IIdependent hypertension. Hypertension 55: 99-108, 2010
17. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH: A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100: 655-669, 2000
18. Okui S, Yamamoto H, Li W, Gamachi N, Fujita Y, Kashiwamura S, Miura D, Takai S, Miyazaki M, Urade M, Okamura H, Ueda H: Cisplatin-induced acute renal failure in mice ismediated by chymase-activated angiotensinaldosterone system and interleukin-18. Eur J Pharmacol 685: 149-155, 2012
19. Perazella MA: Onco-nephrology: Renal toxicities of chemotherapeutic agents. Clin J Am Soc Nephrol 7: 1713-1721, 2012
20. Egami K, Murohara T, Shimada T, Sasaki K, Shintani S, Sugaya T, IshiiM, Akagi T, Ikeda H, Matsuishi T, Imaizumi T: Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth. J Clin Invest 112: 67-75, 2003
21. Cheungpasitporn W, Thongprayoon C, Srivali N, O'Corragain OA, Edmonds PJ, Ungprasert P, Kittanamongkolchai W, Erickson SB: Preoperative renin-angiotensin system inhibitors use linked to reduced acute kidney injury: A systematic review and meta-analysis. Nephrol Dial Transplant 30: 978-988, 2015
22. Mangieri A: Renin-angiotensin system blockers in cardiac surgery. JCritCare30: 613-618, 2015
23. Bedford M, Farmer CK, Irving J, Stevens PE: Acute kidney injury: An acceptable risk of treatment with renin-angiotensin system blockade in primary care? Can J Kidney Health Dis 2: 14, 2015
24. El-Sayed SM, Abd-EllahMF, Attia SM: Protective effect of captopril against cisplatin-induced nephrotoxicity in rats. Pak J Pharm Sci 21: 255-261, 2008
25. Goyal SN, Bharti S, Bhatia J, Nag TC, Ray R, Arya DS: Telmisartan, a dual ARB/partial PPAR-g agonist, protects myocardium from ischaemic reperfusion injury in experimental diabetes. Diabetes Obes Metab 13: 533-541, 2011
26. Seujange Y, Eiam-Ong S, Tirawatnapong T, Eiam-Ong S: Role of angiotensin II on dihydrofolate reductase,GTP-cyclohydrolase 1 and nitric oxide synthase expressions in renal ischemia-reperfusion. Am J Nephrol 28: 692-700, 2008
27. Gurley SB, Riquier-Brison AD, Schnermann J, Sparks MA,Allen AM,Haase VH, Snouwaert JN, Le TH,McDonough AA,KollerBH, Coffman TM: AT1A angiotensin receptors in the renal proximal tubule regulate blood pressure. Cell Metab 13: 469-475, 2011
28. Lee PP, Fitzpatrick DR, Beard C, Jessup HK, Lehar S, Makar KW, Pérez-Melgosa M, Sweetser MT, Schlissel MS, Nguyen S, Cherry SR, Tsai JH, Tucker SM,WeaverWM, Kelso A, Jaenisch R, Wilson CB: A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity 15: 763-774, 2001
29. Shao X, Somlo S, Igarashi P: Epithelialspecific Cre/lox recombination in the developing kidney and genitourinary tract. J Am Soc Nephrol 13: 1837-1846, 2002
30. Grivennikov SI, Tumanov AV, Liepinsh DJ, Kruglov AA, Marakusha BI, Shakhov AN, Murakami T, Drutskaya LN, Förster I, Clausen BE, Tessarollo L, RyffelB, KuprashDV, Nedospasov SA: Distinct and nonredundant in vivo functions of TNF produced by t cells and macrophages/neutrophils: Protective and deleterious effects. Immunity 22: 93-104, 2005
31. Li H, Armando I, Yu P, Escano C, Mueller SC, Asico L, Pascua A, Lu Q, Wang X, Villar VA, Jones JE, Wang Z, Periasamy A, Lau YS, Soares-da-Silva P, Creswell K,Guillemette G, Sibley DR, Eisner G, Gildea JJ, Felder RA, Jose PA:Dopamine 5 receptormediates Ang II type 1 receptor degradation via a ubiquitinproteasome pathway in mice and human cells. J Clin Invest 118: 2180-2189, 2008